P3 Health Partners Inc. $PIII Shares Sold by Trinity Financial Advisors LLC

Key Points

• Trinity Financial Advisors LLC significantly reduced its investment in P3 Health Partners, selling 1,252,537 shares and lowering its position by 98%, leaving it with only 25,500 shares.
• Shares of P3 Health Partners opened at $8.60, with a market cap of $61.83 million and a negative earnings report indicating an EPS of ($6.23), missing analysts' expectations.
• Analysts from Lake Street Capital have initiated coverage on P3 Health Partners with a "buy" rating and a target price of $20.00, reflecting moderate outlook for the stock.

Trinity Financial Advisors LLC trimmed its stake in shares of P3 Health Partners Inc. (NASDAQ:PIII - Free Report) by 98.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 25,500 shares of the company's stock after selling 1,252,537 shares during the quarter. Trinity Financial Advisors LLC owned approximately 0.35% of P3 Health Partners worth $161,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Cresset Asset Management LLC boosted its position in shares of P3 Health Partners by 33.3% in the first quarter. Cresset Asset Management LLC now owns 200,000 shares of the company's stock valued at $33,000 after acquiring an additional 50,000 shares during the period. Abundance Wealth Counselors lifted its position in P3 Health Partners by 77.3% in the 1st quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock worth $66,000 after buying an additional 174,395 shares during the last quarter. Finally, Wealthedge Investment Advisors LLC purchased a new position in shares of P3 Health Partners during the fourth quarter valued at approximately $83,000. 7.75% of the stock is currently owned by institutional investors and hedge funds.

P3 Health Partners Trading Up 5.7%

P3 Health Partners stock traded up $0.44 during midday trading on Friday, reaching $8.01. The stock had a trading volume of 4,464 shares, compared to its average volume of 23,036. The firm has a market cap of $57.56 million, a price-to-earnings ratio of -0.17 and a beta of 0.82. P3 Health Partners Inc. has a twelve month low of $5.80 and a twelve month high of $26.00. The company has a debt-to-equity ratio of 2.29, a current ratio of 0.31 and a quick ratio of 0.31. The firm's fifty day simple moving average is $7.46 and its two-hundred day simple moving average is $7.77.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported ($6.23) EPS for the quarter, missing the consensus estimate of ($3.29) by ($2.94). The firm had revenue of $355.79 million during the quarter, compared to the consensus estimate of $356.52 million. P3 Health Partners had a negative net margin of 9.99% and a negative return on equity of 183.60%. P3 Health Partners has set its FY 2025 guidance at EPS. Equities analysts anticipate that P3 Health Partners Inc. will post -0.67 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital assumed coverage on P3 Health Partners in a report on Thursday, August 28th. They set a "buy" rating and a $20.00 price target for the company. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $16.25.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.